Codexis, Inc.

Codexis, Inc.

Codexis, Inc.

Overview
Date Founded

2002

Headquarters

200 Penobscot Drive, Redwood City, CA, 94063, USA

Type of Company

Public

Employees (Worldwide)

132

Industries

Chemicals
Other Business & Consulting Services
Waste Management & Recycling
Biotechnology

Company Description

Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Contact Data
Trying to get in touch with decision makers at Codexis, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Senior Vice President, Finance & Chief Financial Officer

Senior Vice President, Chief Financial & Accounting Officer

Chief Science Officer Emeritus & Industrial Advisor

Vice President, BioTherapeutics Research & Development

Head-Investor Relations

Senior Director-Molecular Diagnostics

Financial Controller

Director

Director

Board of Directors

Former President, Manufacturing Division at Merck & Co., Inc.

Former Senator from North Dakota

Executive Chairman at Calysta, Inc.

Director at Vitria Technology, Inc.

Executive Vice President & Chief Financial Officer at Five Prime Therapeutics, Inc.

Executive Vice President, Operations & Information Technology at AstraZeneca Plc

Paths to Codexis, Inc.
Potential Connections via
Relationship Science
You
Codexis, Inc.
Owners & Shareholders
Details Hidden

Nantahala Capital Management seeks superior and consistent risk-adjusted returns through investments in equity, fixed-income and equity-derivative securities. The firm will, however, invest in other asset classes of securities as opportunities arise. Nantahala seeks to achieve their clients' objectives through value-oriented securities selection and disciplined risk management.

Details Hidden

Casdin Capital seeks to realize superior long-term adjusted total returns by primarily investing in underappreciated companies with innovative business models in the life sciences and healthcare industry. Their portfolio is generally comprised of small to mid-sized issuers in the following life sciences and healthcare sub-sectors: life sciences instrumentation and information technology, medical testing, drug development and distribution, synthetic biology and agriculture, livestock management and energy production. In addition, the firm also has discretion to invest in certain foreign equity securities if they determine that investments in such securities could generate risk-adjusted returns for their clients. Casdin Capital employs a primary research-intensive approach to investing that is thematically driven and fundamentally based and uses a range of investment strategies, primarily investing in publicly-traded equity or equivalent securities, both long and short, as well as a broad array of other securities.

Details Hidden

Telemark Asset Management seeks to invest primarily in long and short equity positions, but may invest in other types of securities, including debt securities, options and futures. They combine top-down analysis, to assess the various market segments, with bottom-up company specific research. They are likely, at times, to have a high concentration, long or short, in one or more sectors of the market. Telemark's primary objective is long-term performance, which may result in short-term volatility. While their fund is expected to focus on longer-term investments, it may also use short-term investments to protect longer-term positions, or to take advantage of short-term investment opportunities.

Recent Transactions
Details Hidden

Codexis, Inc. issued USD Common Stock

Details Hidden

Codexis, Inc. issued USD Common Stock

Details Hidden

Precigen, Inc. purchases Codexis Laboratories Hungary Kft from Codexis, Inc.

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Escrow Agent

Advised onCodexis, Inc. issued Common Stock

Auditor

Advised onCodexis, Inc. issued USD Common Stock

Underwriter

Advised onCodexis, Inc. issued USD Common Stock

Global Co-Chair, Emerging Company Practice

Advised onCodexis, Inc. issued USD Common Stock

Managing Director, Health Care Investment Banking Group

Advised onCodexis, Inc. issued USD Common Stock

Managing Director

Advised onCodexis, Inc. issued USD Common Stock

Advisors & Consultants
Publicist

Senior Vice President & Principal at Lippert/Heilshorn & Associates, Inc.

Publicist

Professional at That'S Nice LLC

Clients

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

GlaxoSmithKline Plc is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Key Stats and Financials As of 2018
Market Capitalization
$821M
Total Enterprise Value
$819M
Earnings Per Share
$-0.21
Revenue
$60.6M
Net Profit
$-10.9M
EBITDA
$-10.1M
EBITDAMargin
-16.75%
Total Debt
$61K
Total Equity
$56.3M
Enterprise Value Sales
13.51x
TEVNet Income
-75.28x
Debt TEV
0x
Three Year Compounded Annual Growth Rate Of Revenue
13.17%
Five Year Compounded Annual Growth Rate Of Revenue
13.68%
Investors
Details Hidden

Pequot Capital Management's investment philosophy is based on deep fundamental research and unbiased thematic analysis to identify and capitalize on market inefficiencies across an industry sector or a company's lifecycle. The firm invests in public equities, private equity, venture capital, distressed securities and a variety of fixed-income securities.Pequot Capital Management tends to invest in the stocks of US small-cap companies in the consumer services, health technology and commercial services sectors. They maintain a very high turnover rate.

Details Hidden

Chevron Technology Ventures seeks to identify new technologies and business opportunities that can create value for their Chevron Corp., their parent firm. They invest directly in early-stage technology companies and venture capital funds with a focus on the energy and power sectors. The firm also invests in early-stage companies and venture funds outside the energy sector. In addition to external investments, Chevron Technology Ventures invests in promising technology-related business opportunities created by Chevron employees.Chevron Technology Ventures invests in the following industries: (1) information technology hardware and software (2) advanced materials including nanomaterials and MEMs technology (3) networking (4) intelligent devices (5) wireless communications (6) fuel processing and hydrogen infrastructure (7) renewable energy technologies (8) hydrocarbon processing (9) power quality technologies (10) separation (11) catalysis (12) advanced exploration (13) downhole processing and communications (14) deepwater production and development (15) heavy oil upgrading (16) sensors (17) improved production and (18) fuel additives and lubricants.

Details Hidden

CMEA Capital focuses on investments in the life sciences, high technology and energy & materials sectors. They invest in both early- and late-stage ventures.Within the life sciences, the firm invests in biotechnology companies that engage in drug discovery and development. They invest in all stages in medical device companies with evolutionary products that have shorter R&D pathways. They also invest at mid- and late stages in companies with revolutionary products that tend to have longer R&D pathways.Within the high technology sector, CMEA focuses on high performance electronics companies in the consumer electronics and semiconductors markets.Within the energy & materials sector, the firm focuses on future fuels, premium power, alternative generation technologies, energy intelligence and energy efficient products.

Suppliers

Union Agricole Holding AG is a multi-national private company headquartered in Germany. The firm functions as an investment holding company.

ACS Dobfar SpA Wholesale: Consumer Non-Durables/Sundries | Agrate Brianza, MB

ACS Dobfar SpA develops specialty pharmaceutical ingredients. Its products include active pharmaceutical ingredients, finished dosage form and packaging. The company was founded by Marco Falciani in 1973 and is headquartered in Agrate Brianza, Italy.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Synlogic, Inc. Biotechnology - Cambridge, MA

Synlogic, Inc. is a clinical-stage biopharmaceutical company, which engages in drug discovery and development of synthetic biotic medicines. It focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also works on SYNB1891, an intratumorally administered which treats cancer. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA.

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Codexis, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Codexis, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Codexis, Inc..